Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas
Abstract Hepatobiliary cancer is the third leading cause of cancer death worldwide. Appropriate markers for early diagnosis, monitoring of disease progression, and prediction of postsurgical outcome are still lacking. As the majority of circulating N‐glycoproteins are originated from the hepatobilia...
Main Authors: | Ting‐Tsung Chang, Ji‐Hong Cheng, Hung‐Wen Tsai, Kung‐Chia Young, Sun‐Yuan Hsieh, Cheng‐Hsun Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-07-01
|
Series: | The Journal of Pathology: Clinical Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/cjp2.136 |
Similar Items
-
Fucosyl-Agalactosyl IgG<sub>1</sub> Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage
by: Ting-Tsung Chang, et al.
Published: (2018-11-01) -
O-glycoprofiling of Serum Apolipoprotein C-III in Colorectal Cancer
by: Kristína Kianičková, et al.
Published: (2024-01-01) -
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
by: Giuliana Cavalloni, et al.
Published: (2021-07-01) -
Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications
by: Andrei M. Jipa, et al.
Published: (2024-03-01) -
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States
by: Michael H. Storandt, et al.
Published: (2024-02-01)